◀ Back to CD79A

CD79A — VIP

Text-mined interactions from Literome

Ishioka et al., Clin Exp Immunol 1992 : VIP also enhanced IgA production and thymidine uptake by purified tonsil B cells
Kimata et al., Eur J Immunol 1994 : The effects of vasoactive intestinal peptide (VIP) on human IgA1 and IgA2 production were studied ... In unfractionated small resting B cells stimulated with anti-CD40 monoclonal antibody ( mAb ), VIP induced IgA1 and IgA2 production without affecting the production of IgG1, IgG2, IgG3, IgG4, IgM, or IgE ... When small B cells were separated into sIgA1+, sIgA2+, sIgA1- and sIgA2- B cells, anti-CD40 mAb plus VIP induced IgA1 and IgA2 production by surface IgA1- ( sIgA1- ) and sIgA2- B cells, respectively, while having no effect on sIgA1+ and sIgA2+ B cells ... These results indicate that in the presence of anti-CD40 mAb, VIP induces IgA1 and IgA2 production by isotype switching
Kimata et al., Blood 1995 : Induction of IgA1 and IgA2 production in immature human fetal B cells and pre-B cells by vasoactive intestinal peptide ... We studied the effects of vasoactive intestinal peptide (VIP) on IgA1 and IgA2 production in human fetal B cells and pre-B cells derived from bone marrow ... VIP induced IgA1 , IgA2, and IgM production in sIgM+, CD19+ fetal B cells stimulated with anti-CD40 monoclonal antibody ( MoAb ) without inducing the production of IgG1, IgG2, IgG3, IgG4, or IgE ... These findings indicate that, in the presence of costimulators, VIP may induce IgA1 and IgA2 production by isotype switching
Kimata et al., Adv Neuroimmunol 1996 : In anti-CD40 mAb stimulated B cells from nonatopic donors, VIP selectively induced IgA1 and IgA2 production without affecting IgG1, IgG2, IgG3, IgG4, IgM, or IgE production